| OVERVIEW |
| bs-11150R-PE-Cy5 |
| PCDHGA9 Polyclonal Antibody, PE-Cy5 Conjugated |
| WB |
| Human, Mouse, Rat |
| SPECIFICATIONS |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PCDHGA9 |
| 351-450/932 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| TARGET |
| 56107 |
| Cell membrane |
| PCDH-gamma-A9; Protocadherin gamma A9; PCDG9_HUMAN. |
| Protocadherins are a large family of cadherin-like cell adhesion proteins that are involved in the establishment and maintenance of neuronal connections in the brain. There are three protocadherin (PCDH) gene clusters, designated alpha, beta and gamma, all of which contain multiple tandemly arranged genes. PCDHGA9 (Protocadherin gamma-A9) is a 932 amino acid that is one of 22 proteins encoded by the protocadherin gamma cluster. The protocadherein gamma cluster consists of three subfamilies (A, B and C) and PCDHGA9 is a member of the gamma subfamily A. PCDHGA9 is a type I transmembrane receptor containing six cadherin motifs and is expressed in the central nervous system where it localizes to synapses. Members of the gamma cluster of protocadherins are essential for neuronal survival. There are two isoforms of PCDHGA9 that are produced as a result of alternative splicing events. |
| APPLICATION DILUTION |
| WB |
1:300-5000 |
|
|
|
|
|
|
Powered by Bioz